首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症癌症診斷

市場調查報告書

商品編碼

1547694

全球前列腺癌診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Prostate Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球前列腺癌診斷市場需求預計將從 2023 年的 91.3 億美元達到近 165.5 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.83%。

前列腺癌是男性最常見的癌症類型之一。這種癌症出現在男性前列腺的一個核桃形小腺體中，該腺體產生滋養和運輸精子的精液。健康從業者會進行測試來分析和理解其嚴重性，並了解惡性生長是否已從起始部位擴散到身體的其他部位。醫生也可能會進行測試來了解哪種治療方法最有效。大多數前列腺癌是透過 PSA 測試、CTC 測試、免疫組織化學、直腸指檢、影像學測試和 PCA3 測試篩檢而首次發現的。

市場動態

全球前列腺癌盛行率的上升正在推動全球前列腺癌診斷市場的發展。攝護腺癌是全球第五大死因，也是男性第二常見的癌症診斷。根據GLOBOCAN估計，2018年全球新增攝護腺癌病例1,276,106例，其中已開發國家的負擔較高。全球盛行率的差異反映了診斷檢測使用的差異。然而，農村地區缺乏意識、高昂的診斷成本和醫療設施不足阻礙了市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球前列腺癌診斷市場的每個細分市場進行了包容性評估。前列腺癌診斷產業的成長和趨勢為本研究提供了整體方法。

市場區隔

前列腺癌診斷市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按測試類型

初步測試（PSA測試、免費PSA測試、總PSA測試、其他初步測試）
驗證性測試（Pca3 測試、經直腸超音波檢查、活體組織切片測試）

按類型展望

腺癌
間質細胞癌
其他

按最終用途

醫院
門診設施
居家護理
研究與製造

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲前列腺癌診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。攝護腺癌診斷市場的主要參與者包括 MDx Health、Myriad Genetics Inc.、Abbott Laboratories、F. Hoffman-La Roche AG、Bayer AG、Siemens Healthcare GmbH、OPKO Health Inc.、Genomic Health.、輝瑞公司。格局的整體看法，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：前列腺癌診斷公司的競爭格局

前列腺癌診斷市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
MDx Health

公司概況
公司收入
產品
最新動態

Myriad Genetics Inc.

公司概況
公司收入
產品
最新動態

Abbott Laboratories

公司概況
公司收入
產品
最新動態

F. Hoffman-La Roche AG

公司概況
公司收入
產品
最新動態

Bayer AG

公司概況
公司收入
產品
最新動態

Siemens Healthcare GmbH

公司概況
公司收入
產品
最新動態

OPKO Health Inc.

公司概況
公司收入
產品
最新動態

Genomic Health.

公司概況
公司收入
產品
最新動態

Pfizer Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11213873

The global demand for Prostate Cancer Diagnostics Market is presumed to reach the market size of nearly USD 16.55 Billion by 2032 from USD 9.13 Billion in 2023 with a CAGR of 6.83% under the study period 2024-2032.

Prostate cancer is among the most frequent cancer type in the male. This cancer appears in the prostate in a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. Health practitioners do tests to analyze and comprehend the seriousness and learn if malignant growth has spread to other body locations from where it started. Doctors may also do tests to know which treatments could work best. Most prostate cancers are first found due to screening with PSA tests, CTC tests, immunohistochemistry, digital rectal exam, imaging test, and PCA3 test.

MARKET DYNAMICS

The rising prevalence of prostate cancer worldwide is driving the global prostate cancer diagnostics market. Prostate cancer is the fifth dominating cause of death worldwide and the second most frequent cancer diagnosis made in men. According to GLOBOCAN estimates, in 2018, 1,276,106 new prostate cancer cases were reported globally, with a higher burden in the developed countries. Differences in the prevalence rates worldwide reflect differences in the use of diagnostic testing. However, lack of awareness, high cost of diagnosis, and inadequate healthcare facilities in rural areas hinder the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Prostate Cancer Diagnostics. The growth and trends of Prostate Cancer Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Prostate Cancer Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests)
Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test)

By Type Outlook

Adenocarcinoma
Interstitial Cell Carcinoma
Other

By End Use

Hospitals
Outpatient Facilities
Home Care
Research & Manufacturing

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Prostate Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Prostate Cancer Diagnostics market include MDx Health, Myriad Genetics Inc., Abbott Laboratories, F. Hoffman-La Roche AG, Bayer AG, Siemens Healthcare GmbH, OPKO Health Inc., Genomic Health., Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROSTATE CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Type Outlook
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

5.1. Overview By Test Type
5.2. Historical and Forecast Data
5.3. Analysis By Test Type
5.4. Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests) Historic and Forecast Sales By Regions
5.5. Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test) Historic and Forecast Sales By Regions

6. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE OUTLOOK

6.1. Overview By Type Outlook
6.2. Historical and Forecast Data
6.3. Analysis By Type Outlook
6.4. Adenocarcinoma Historic and Forecast Sales By Regions
6.5. Interstitial Cell Carcinoma Historic and Forecast Sales By Regions
6.6. Other Historic and Forecast Sales By Regions

7. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Outpatient Facilities Historic and Forecast Sales By Regions
7.6. Home Care Historic and Forecast Sales By Regions
7.7. Research & Manufacturing Historic and Forecast Sales By Regions

8. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PROSTATE CANCER DIAGNOSTICS COMPANIES

9.1. Prostate Cancer Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PROSTATE CANCER DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. MDx Health
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Myriad Genetics Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Abbott Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. F. Hoffman-La Roche AG
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Bayer AG
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Siemens Healthcare GmbH
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. OPKO Health Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Genomic Health.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Pfizer Inc
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Test Type (USD MN)
Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests) Market Sales By Geography (USD MN)
Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test) Market Sales By Geography (USD MN)
Analysis By Type Outlook (USD MN)
Adenocarcinoma Market Sales By Geography (USD MN)
Interstitial Cell Carcinoma Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Analysis By End Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Outpatient Facilities Market Sales By Geography (USD MN)
Home Care Market Sales By Geography (USD MN)
Research & Manufacturing Market Sales By Geography (USD MN)
Global Prostate Cancer Diagnostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Prostate Cancer Diagnostics Report
Market Research Process
Market Research Methodology
Global Prostate Cancer Diagnostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Test Type
Market Attractiveness Analysis By Type Outlook
Market Attractiveness Analysis By End Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Test Type (USD MN)
Preliminary Tests (PSA Tests, Free PSA Test, Total PSA Test, Other Preliminary Tests) Market Sales By Geography (USD MN)
Confirmatory Tests (Pca3 Test, Trans-Rectal Ultrasound, Biopsy Test) Market Sales By Geography (USD MN)
Global Market Analysis By Type Outlook (USD MN)
Adenocarcinoma Market Sales By Geography (USD MN)
Interstitial Cell Carcinoma Market Sales By Geography (USD MN)
Other Market Sales By Geography (USD MN)
Global Market Analysis By End Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Outpatient Facilities Market Sales By Geography (USD MN)
Home Care Market Sales By Geography (USD MN)
Research & Manufacturing Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis